Overview

Dronabinol Interactions With Cognitive Enhancing Drug in Humans

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Marijuana use is a major problem among veterans and non-veterans. A patient's use of marijuana while engaged in psychotherapy treatment may affect their memory and, therefore, limit their ability to benefit from treatment. This study is designed to test a new pharmacotherapy, modafinil, which has the potential to improve memory functioning in marijuana using individuals. We hypothesize that modafinil treatment will decrease ratings of drug liking and improve cognitive measures, especially episodic memory.
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University
Collaborators:
National Institute on Drug Abuse (NIDA)
VA Office of Research and Development
Treatments:
Armodafinil
Dronabinol
Modafinil